Medicus Pharma Ltd. (MDCX) Stock Profile — Insider Trades & Financials

Net Income-$15.1M

EPS$-1.91

Market Cap$18.1M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Raza Bokhari

CEO & Executive Director

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.

Founded: 2008
Headquarters: Conshohocken, Pennsylvania, United States
Website

⚡

Core Efficiency

ROE?

22304.04%

ROA?

-149.75%

D/E Ratio?

-148.39

📊

Profitability Ratios

Current Ratio?

1.00

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Sep 11, 2026 (in 155 days)

Annual Report (10-K) — Based on filing pattern

Sep 11, 2026

Predicted10-K

Mar 25, 2026

10-KQ4 20258d after period end

Mar 25, 2026

10-KFY 202584d after period end

Nov 14, 2025

10-QQ3 20253d after period end

Aug 11, 2025

10-QQ2 20250d after period end

May 12, 2025

10-QQ1 20254d after period end

Apr 30, 2025

10-K/AQ4 202415d after period end

Mar 28, 2025

10-KFY 202587d after period end

Loading company sections...

Medicus Pharma Ltd.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness